Intellia Therapeutics Inc. (NTLA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Intellia Therapeutics Inc...

NASDAQ: NTLA · Real-Time Price · USD
19.96
-0.48 (-2.35%)
At close: Oct 03, 2025, 3:59 PM
20.08
0.60%
After-hours: Oct 03, 2025, 07:58 PM EDT

Intellia Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
189.18M 226.75M 523.51M 123.41M
Short-Term Investments
412.33M 685.48M 669.12M 625.28M
Long-Term Investments
44.26M 154.51M 142.32M 425.05M
Other Long-Term Assets
260.21M n/a n/a n/a
Receivables
8.52M 36.46M 3.77M 2.03M
Inventory
n/a n/a -69.34M n/a
Other Current Assets
29.83M 49.65M 89.75M n/a
Total Current Assets
639.86M 998.33M 1.22B 769.3M
Property-Plant & Equipment
246.67M 148.13M 161M 100.11M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
551.15M 302.65M 303.32M 525.16M
Total Assets
1.19B 1.3B 1.52B 1.29B
Account Payables
14.59M 7.45M 5.15M 9.65M
Deferred Revenue
20.66M 22.14M 43.84M 63.76M
Short-Term Debt
n/a n/a 16.68M 9.11M
Other Current Liabilities
55.35M 6.89M 22.41M 13.84M
Total Current Liabilities
110.85M 115.21M 126.55M 125.83M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 38.85M 24.03M 63.48M
Total Long-Term Liabilities
208.21M 135.6M 157.98M 128.39M
Total Liabilities
319.06M 250.81M 284.53M 254.22M
Total Debt
210.2M 115.35M 130.7M 74.02M
Book Value
871.96M 1.05B 1.24B 1.04B
Book Value Per Share
8.82 11.83 16.05 14.67
Common Stock
10K 9K 9K 7K
Retained Earnings
-2.18B -1.66B -1.18B -703M
Comprehensive Income
605K -2.26M -7.46M -2.63M
Shareholders Equity
871.96M 1.05B 1.24B 1.04B
Total Investments
456.6M 839.99M 811.44M 1.05B